EL PASO, Texas (KFOX14/CBS4) — Scientists at The University of Texas at El Paso have identified a promising new target in the battle against high-grade serous carcinoma, a particularly aggressive form of ovarian cancer.
According to the research team, less than 50% of women survive five years after being diagnosed with this type of cancer.
A study published in “Scientific Reports” reveals that Claudin-4, a protein that increases in ovarian cancer, may contribute to the cancer’s resistance by helping tumors evade the body’s immune system…